Anúncio
Anúncio
LENZ
LENZ Therapeutics, Inc. Common Stock
14.87
USDPatrocinado
-0.37
-2.43%
09 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
14.95
+0.08
+0.54%
Relatórios de Lucros LENZ
Rácio de surpresa positiva
LENZ separação 9 de 18 últimas estimativas.
50%
Próximo Relatório
Data do Próximo Relatório
09 de mar. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$2.00M
/-$0.99
Mudanças implicadas de Q3 25 (Revenue/ EPS)
-83.99%
/+67.80%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
--
/+115.22%
LENZ Therapeutics, Inc. Common Stock earnings per share and revenue
On 05 de nov. de 2025, LENZ reported earnings of -0.59 USD per share (EPS) for Q3 25, beating the estimate of -0.72 USD, resulting in a 18.10% surprise. Revenue reached 12.50 milhão, compared to an expected 6.96 milhão, with a 79.48% difference. The market reacted with a -23.46% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 analistas forecast an EPS of -0.99 USD, with revenue projected to reach 2.00 milhão USD, implying an aumentar of 67.80% EPS, and diminuir of -83.99% in Revenue from the last quarter.
FAQ
What were LENZ Therapeutics, Inc. Common Stock's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, LENZ Therapeutics, Inc. Common Stock reported EPS of -$0.59, beating estimates by 18.1%, and revenue of $12.50M, 79.48% above expectations.
How did the market react to LENZ Therapeutics, Inc. Common Stock's Q3 2025 earnings?
The stock price moved down -23.46%, changed from $28.05 before the earnings release to $21.47 the day after.
When is LENZ Therapeutics, Inc. Common Stock expected to report next?
The next earning report is scheduled for 09 de mar. de 2026.
What are the forecasts for LENZ Therapeutics, Inc. Common Stock's next earnings report?
Based on 8
analistas, LENZ Therapeutics, Inc. Common Stock is expected to report EPS of -$0.99 and revenue of $2.00M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio